Table 7.
Prior medication for hidradenitis suppurativa
| Prior medication | Adults N = 529 |
Adolescents N = 65 |
All patients N = 594 |
|---|---|---|---|
| Any category of prior medication | 391 (73.9) | 44 (67.7) | 435 (73.2) |
| Retinoids | 98 (18.5) | 7 (10.8) | 105 (17.7) |
| Antibiotics | 365 (69.0) | 41 (63.1) | 406 (68.4) |
| Corticosteroids | 47 (8.9) | 5 (7.7) | 52 (8.8) |
| Opioids | 7 (1.3) | 1 (1.5) | 8 (1.3) |
| Biologics | 29 (5.5) | 0 | 29 (4.9) |
| Hormonal therapies | 25 (4.7) | 1 (1.5) | 26 (4.4) |
| Immunosuppressants | 6 (1.1) | 2 (3.1) | 8 (1.3) |
| Reasons for discontinuing prior HS medicationb | N = 411 | N = 47 | N = 458 |
| Treatment failure or inadequate response | 234 (56.9) | 20 (42.6) | 254 (55.5) |
| Treatment not tolerated | 64 (15.6) | 8 (17.0) | 72 (15.7) |
| Satisfactory remission | 66 (16.1) | 16 (34.0) | 82 (17.9) |
| Complete remission | 13 (3.2) | 3 (6.4) | 16 (3.5) |
| Othera | 34 (8.3) | 0 | 34 (7.4) |
Data are presented as N (%)
HS hidradenitis suppurativa
a“Other” mainly includes patients who were prescribed a short course of therapy
bFor patients with any previous treatment for hidradenitis suppurativa